Your session is about to expire
← Back to Search
NTM Monitoring for Neonatal Hypothermia
N/A
Waitlist Available
Led By Rebecca Richards-Kortum, PhD
Research Sponsored by William Marsh Rice University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up <72 hours
Awards & highlights
Study Summary
This study is evaluating whether a new temperature sensor may be able to help prevent infant hypothermia.
Eligible Conditions
- Neonatal Hypothermia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ <72 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~<72 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Temperature measurement accuracy
Trial Design
1Treatment groups
Experimental Treatment
Group I: Neonatal Temperature MonitorExperimental Treatment1 Intervention
One or more test devices (NTM, Bempu, Thermospot) will be attached to the infant in the neonatal intensive care unit (NICU) or KMC ward along with the Philips Intellivue patient monitor. Temperature will be monitored continuously using each device for up to 72 hours.
Find a Location
Who is running the clinical trial?
Kamuzu University of Health SciencesOTHER
66 Previous Clinical Trials
81,725 Total Patients Enrolled
1 Trials studying Neonatal Hypothermia
150 Patients Enrolled for Neonatal Hypothermia
University of Malawi College of MedicineOTHER
56 Previous Clinical Trials
65,645 Total Patients Enrolled
1 Trials studying Neonatal Hypothermia
150 Patients Enrolled for Neonatal Hypothermia
William Marsh Rice UniversityLead Sponsor
45 Previous Clinical Trials
27,703 Total Patients Enrolled
3 Trials studying Neonatal Hypothermia
330 Patients Enrolled for Neonatal Hypothermia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger